Quimperle

Head injuries are common reasons for emergency room visits, with most being minor traumas. This research evaluates whether patients treated with antiplatelet inhibitors who have a head injury but no other risk factors listed in the NICE criteria truly require a CT scan to check for cerebral hemorrhage. The study addresses the uncertainty in medical literature about whether antiplatelet treatment alone indicates the need for a CT scan after head trauma. Participants who take antiplatelet inhibitors and have experienced a head injury will first undergo a clinical examination. Following this exam, they will receive a CT scan to detect any cerebral hemorrhage. This is a diagnostic, prospective, multicenter study where the primary outcome—the presence of cerebral hemorrhage—is assessed blindly. After one month, participants will be contacted to report any related health issues or mortality. During the study, researchers will collect clinical exam data, CT scan results, and follow-up information on participant health status. The main outcome measured is the detection of cerebral hemorrhage via CT scan one day after injury. Safety and health status will be monitored for a month post-injury to observe any delayed complications. Total participation involves initial clinical and imaging assessments plus a one-month follow-up call.